Next Article in Journal
Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition
Previous Article in Journal
Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(2), 243; https://doi.org/10.3390/ph15020243
Action Date Notes Link
article xml file uploaded 18 February 2022 11:33 CET Original file -
article xml uploaded. 18 February 2022 11:33 CET Update -
article pdf uploaded. 18 February 2022 11:33 CET Version of Record https://www.mdpi.com/1424-8247/15/2/243/pdf-vor
article supplementary file uploaded. 18 February 2022 11:33 CET - https://www.mdpi.com/1424-8247/15/2/243#supplementary
article html file updated 18 February 2022 11:34 CET Original file -
article xml file uploaded 24 February 2022 03:44 CET Update -
article xml uploaded. 24 February 2022 03:44 CET Update https://www.mdpi.com/1424-8247/15/2/243/xml
article pdf uploaded. 24 February 2022 03:44 CET Updated version of record https://www.mdpi.com/1424-8247/15/2/243/pdf
article html file updated 24 February 2022 03:46 CET Update -
article html file updated 31 July 2022 22:30 CEST Update https://www.mdpi.com/1424-8247/15/2/243/html
Back to TopTop